Russell Investments Group’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$127K Buy
171,809
+171,629
+95,349% +$132K ﹤0.01% 3397
2026
Q2
$148 Sell
180
-21,454
-99% -$20.3K ﹤0.01% 4252
2026
Q1
$19.9K Sell
21,634
-3,504
-14% -$4.24K ﹤0.01% 3624
2025
Q4
$32.2K Buy
25,138
+117
+0.5% +$157 ﹤0.01% 3466
2025
Q3
$32.5K Buy
25,021
+24,211
+2,989% +$31.7K ﹤0.01% 3434
2025
Q2
$972 Buy
+810
New +$898 ﹤0.01% 3671
2025
Q1
– Sell
-220
Closed -$385 – 3840
2024
Q4
$385 Hold
220
– – ﹤0.01% 3633
2024
Q3
$425 Hold
220
– – ﹤0.01% 3585
2024
Q2
$389 Hold
220
– – ﹤0.01% 3518
2024
Q1
$596 Buy
+220
New +$531 ﹤0.01% 3186
2020
Q4
– Sell
-106,289
Closed -$788K – 3125
2020
Q3
$788K Sell
106,289
-1,324,628
-93% -$9.14M ﹤0.01% 2169
2020
Q2
$5.74M Sell
1,430,917
-5,840,328
-80% -$20.3M 0.01% 1019
2020
Q1
$18.5M Buy
7,271,245
+1,411,413
+24% +$4.64M 0.05% 430
2019
Q4
$20.4M Buy
5,859,832
+1,850,282
+46% +$6.51M 0.04% 536
2019
Q3
$18.6M Sell
4,009,550
-1,428,479
-26% -$11.3M 0.04% 568
2019
Q2
$67M Sell
5,438,029
-149,060
-3% -$1.9M 0.13% 192
2019
Q1
$74.2M Buy
5,587,089
+423,877
+8% +$4.47M 0.14% 164
2018
Q4
$44.5M Buy
5,163,212
+889,727
+21% +$6.93M 0.1% 231
2018
Q3
$32M Sell
4,273,485
-121,465
-3% -$863K 0.06% 366
2018
Q2
$26.2M Buy
4,394,950
+684,781
+18% +$3.9M 0.05% 417
2018
Q1
$21.7M Sell
3,710,169
-121,070
-3% -$795K 0.04% 574
2017
Q4
$23.6M Buy
3,831,239
+383,748
+11% +$2.1M 0.04% 565
2017
Q3
$17.4M Buy
3,447,491
+1,099,072
+47% +$4.62M 0.03% 693
2017
Q2
$9.48M Buy
2,348,419
+89,482
+4% +$424K 0.02% 942
2017
Q1
$12.8M Buy
2,258,937
+19,725
+0.9% +$125K 0.02% 745
2016
Q4
$16.1M Buy
2,239,212
+540,558
+32% +$3.39M 0.03% 641
2016
Q3
$13.6M Buy
1,698,654
+256,837
+18% +$2.36M 0.03% 707
2016
Q2
$13M Buy
1,441,817
+309,540
+27% +$2.91M 0.02% 802
2016
Q1
$9.14M Buy
+1,132,277
New +$8.17M 0.02% 1001
2015
Q2
– Sell
-300,771
Closed -$12.7M – 3058
2015
Q1
$12.7M Buy
300,771
+67,652
+29% +$2.67M 0.02% 775
2014
Q4
$7.82M Sell
233,119
-988
-0.4% -$28K 0.01% 1014
2014
Q3
$5.74M Buy
234,107
+33,052
+16% +$929K 0.01% 1198
2014
Q2
$5.91M Buy
201,055
+65,105
+48% +$2.09M 0.01% 1219
2014
Q1
$4.9M Buy
135,950
+7,795
+6% +$343K 0.01% 1315
2013
Q4
$5.44M Buy
128,155
+3,505
+3% +$103K 0.01% 1177
2013
Q3
$2.8M Buy
124,650
+124,495
+80,319% +$2.45M ﹤0.01% 1676
2013
Q2
$3K Hold
155
– – ﹤0.01% 3149

Other funds holding LAB

Russell Investments Group's LAB Position: Q3 2026 in Review

Russell Investments Group increased its Standard BioTools (LAB) stake by 95,349% in Q3 2026, buying an estimated $132K and bringing the position to 171,809 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #3397.

Russell Investments Group first reported a position in LAB in Q2 2013 and has held it in 37 quarters since. The position peaked at $74.2M in Q1 2019. 104 funds tracked by Wall St. Rank hold LAB as of Q3 2026.

  • Russell Investments Group held 171,809 shares of Standard BioTools worth $127K as of Q3 2026.
  • Russell Investments Group bought 171,629 Standard BioTools shares in Q3 2026, an estimated $132K.
  • Standard BioTools made up ﹤0.01% of Russell Investments Group's portfolio in Q3 2026, its #3397 holding.
  • Russell Investments Group first reported a position in Standard BioTools in Q2 2013 and has held it in 37 quarters since.
  • Russell Investments Group's Standard BioTools position peaked at $74.2M in Q1 2019.
  • 104 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.

Based on Russell Investments Group's 13F filing for Q3 2026, filed 6 Nov 2026.